The revenue stands at ₹4,173.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.85 per cent from ₹4,295.50 crore. This corresponds to a year-on-year *(YoY) growth of 9.20 per cent.
Operating Profit stands at ₹540.10 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 34.41 per cent from ₹823.50 crore. This corresponds to a year-on-year *(YoY) decline of 28.16 per cent.
PBDT stands at ₹447.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 30.54 per cent from ₹644.30 crore. This corresponds to a year-on-year *(YoY) decline of 23.02 per cent.
Profit Before Tax stands at ₹-67.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 139.58 per cent from ₹171.30 crore. This corresponds to a year-on-year *(YoY) decline of 143.49 per cent.
Net Profit stands at ₹-51.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 139.01 per cent from ₹132.80 crore. This represents a 163.87 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Biocon | -2.28% | -2.47% | -5.53% | -4.27% | -2.82% | 9.04% |
| Glenmark Pharma. | -1.68% | 3.07% | 5.88% | 14.84% | 26.81% | 63.13% |
| Alkem Lab | -5.48% | -7.21% | -2.15% | -9.14% | -4.43% | 4.11% |
| Laurus Labs | -1.37% | -1.43% | 10.32% | 11.39% | 18.38% | 77.75% |
| Abbott India | -0.79% | -1.49% | -3.66% | -8.98% | -15.39% | -15.30% |
| Glaxosmi. Pharma | -0.47% | 1.68% | 9.47% | 5.73% | -7.95% | -13.19% |
| Anthem Bioscienc | -0.07% | 2.18% | 8.56% | 24.90% | 0.91% | 1.25% |
Chairperson : Kiran Mazumdar Shaw
Non Executive Director : Ravi Mazumdar
Independent Director : Bobby Parikh
Non Executive Director : Eric Vivek Mazumdar
Lead Independent Director : Naina Lal Kidwai
Independent Director : Atul Dhawan
Independent Director : Rekha Mehrotra Menon
Independent Director : NICHOLAS ROBERT HAGGAR
Company Sec. & Compli. Officer : Ekta Agarwal
Managing Director & Chief Executive Officer : Shreehas Pradeep Tambe